Cancer statistics, 2023

Siegel, Rebecca L., Miller, Kimberly D., Wagle, Nikita Sandeep, Jemal, Ahmedin·2023·CA: A Cancer Journal for Clinicians

Cited by (1,028)

Items 101–200 of 1,028

  1. Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia
    Cooper Quartermaine, Sanam Mir Ghazi, Aneeq Yasin, Farrukh Tauseef Awan, Michael G. Fradley, Tracy E. Wiczer, Sujay Kalathoor, Mussammat Ferdousi, Satyam Krishan, Alma Habib et al. · 2023 · JACC CardioOncology
  2. Metabolic Recoding of NSUN2‐Mediated m 5 C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m 5 C‐ENO1 Positive Feedback Loop
    Baoxiang Chen, Yanrong Deng, Yuntian Hong, Lifang Fan, Xiang Zhai, Heng Hu, Siyuan Yin, Quanjiao Chen, Xiaoyu Xie, Xianghai Ren et al. · 2024 · Advanced Science
  3. Estrogens and the risk of breast cancer: A narrative review of literature
    Khayry Al‐Shami, Sajeda Awadi, Almu’atasim Khamees, Ahmad Malek Alsheikh, Sumaiya Al-Sharif, Raneem Bereshy, Sharaf F. Al-Eitan, Sajedah H. Banikhaled, Ahmad Rajeh Al-Qudimat, Raed M. Al‐Zoubi et al. · 2023 · Heliyon
  4. Advanced disease therapeutics using engineered living drug delivery systems
    Narsimha Mamidi, Fátima Franco De Silva, Amin Orash Mahmoud Salehi · 2025 · Nanoscale
  5. American Cancer Society’s report on the status of cancer disparities in the United States, 2023
    Farhad Islami, Jordan Baeker Bispo, Hyunjung Lee, Daniel Wiese, K. Robin Yabroff, Priti Bandi, Kirsten Sloan, Alpa V. Patel, Elvan C. Daniels, Arif H. Kamal et al. · 2023 · CA A Cancer Journal for Clinicians
  6. How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies?
    David Musheyev, Alexander Pan, Stacy Loeb, Abdo E. Kabarriti · 2023 · European Urology
  7. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
    Junjiang Fu, Saber İmani, Mei-Yi Wu, Ray‐Chang Wu · 2023 · Cancers
  8. Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
    Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, Afshin Arti, Karim Nayernia, Babak Behnam · 2024 · Biomedicines
  9. Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
    Kelly, William K., Danila, Daniel C., Lin, Chia-Chi, Lee, Jae-Lyun, Matsubara, Nobuaki, Ward, Patrick J., Armstrong, Andrew J., Pook, David, Kim, Miso, Dorff, Tanya B. et al. · 2024 · Cancer Discovery
  10. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study
    Michael David Chuong, Percy P. Lee, Daniel A. Low, Joshua P. Kim, Kathryn Elizabeth Mittauer, Michael Frederick Bassetti, Carri K. Glide‐Hurst, Ann Caroline Raldow, Yingli Yang, Lorraine Portelance et al. · 2023 · Radiotherapy and Oncology
  11. Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
    Qianru Li, Chao Ding, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Nuopei Tan et al. · 2024 · Chinese Medical Journal
  12. Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
    Saurav Kumar Jha, Gabriele De Rubis, Shankar Raj Devkota, Yali Zhang, Radhika Adhikari, Laxmi Akhileshwar Jha, Kunal Bhattacharya, Samir Mehndiratta, Gaurav Gupta, Sachin Kumar Singh et al. · 2024 · Ageing Research Reviews
  13. Uses and Limitations of Artificial Intelligence for Oncology
    Kolla, Likhitha, Parikh, Ravi B. · 2024 · Cancer
  14. Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
    Antonio González-Martı́n, Bhavana Pothuri, Ignace B. Vergote, Whitney A. Spannuth Graybill, Domenica Lorusso, Colleen McCormick, Gilles Freyer, Floor Jenniskens Backes, Florian Heitz, Andrés Redondo et al. · 2023 · European Journal of Cancer
  15. Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
    Bolin Wang, Jinli Pei, Shengnan Xu, Jie Liu, Jinming Yu · 2023 · Frontiers in Immunology
  16. Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
    Francesco M. Lasorsa, Monica Rutigliano, Martina Milella, Matteo Ferro, Savio Domenico Pandolfo, Felice Crocetto, Octavian Sabin Tătaru, Riccardo Autorino B, Michele Battaglia, Pasquale Ditonno et al. · 2023 · Journal of Clinical Medicine
  17. Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy
    Ruoxi Zhao, Yanlin Zhu, Lili Feng, Bin Liu, Yaoyu Hu, Haixia Zhu, Zhiyu Zhao, He Ding, Shili Gai, Piaoping Yang · 2023 · Advanced Materials
  18. Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
    Yanhong Duo, Lei Han, Yaoqiang Yang, Zhifeng Wang, Lirong Wang, Jingyi Chen, Zhongyuan Xiang, Juyoung Yoon, Guanghong Luo, Ben Zhong Tang · 2024 · Chemical Reviews
  19. Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis
    Zhiting Liu, Yingyu Zhou, Jia Lü, Ting Gong, Elena Ibáñez, Alejandro Cifuentes, Weihong Lu · 2024 · Biomarker Research
  20. Chemiluminescent probes in cancer biology
    Rachel Blau, Omri Shelef, Doron Shabat, Ronit Satchi‐Fainaro · 2023 · Nature Reviews Bioengineering
  21. Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments
    Thi Khanh Le, Quang Hieu Duong, Virginie Baylot, Christelle Fargette, Michaël Baboudjian, Laurence Colleaux, David Taïeb, Palma Rocchi · 2023 · Cancers
  22. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
    Zhipeng Li, Huaxin Zhou, Xiangyu Zhai, Lin Gao, Mengfan Yang, Baokun An, Tong Xia, Gang Du, Xiaoming Li, Wei Wang et al. · 2023 · Cell Death and Disease
  23. Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
    Edward K. Avila, Steven D. Tobochnik, Sara K. Inati, Johan A F Koekkoek, Guy M. McKhann, James John Riviello, Roberta Rudà, David Schiff, William O. Tatum, Jessica W. Templer et al. · 2023 · Neuro-Oncology
  24. Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account
    Roberta Vitale, Stefania Marzocco, Ada Popolo · 2024 · International Journal of Molecular Sciences
  25. Advances in the management of pancreatic cancer
    Marco Del Chiaro, Toshitaka Sugawara, Sana D. Karam, Wells A. Messersmith · 2023 · BMJ
  26. Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI
    Leon Marcel Bischoff, Johannes Peeters, Leonie Weinhold, Philipp Krausewitz, Jörg Ellinger, Christoph Katemann, Alexander Isaak, Oliver M. Weber, Daniel L. R. Kuetting, Ulrike Irmgard Attenberger et al. · 2023 · Radiology
  27. Lung Cancer Classification Using Modified U-Net Based Lobe Segmentation and Nodule Detection
    Iftikhar Naseer, Sheeraz Akram, Tehreem Masood, Muhammad Rashid, Arfan Jaffar · 2023 · IEEE Access
  28. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
    Baofa Yu, Shengwen Shao, Wenxue Ma · 2024 · Cancer Letters
  29. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target
    Conner Daniel Hartupee, Bolni Marius Nagalo, Chiswili Yves Chabu, Mulu Z. Tesfay, Joycelynn Coleman‐Barnett, John T. West, Omeed Moaven · 2024 · Frontiers in Immunology
  30. Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
    A. Trabolsi, Artavazd Arumov, J. Schatz · 2024 · Blood Cancer Journal
  31. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
    Stefanoudakis, Dimitrios, Frountzas, Maximos, Schizas, Dimitrios, Michalopoulos, Nikolaos V., Drakaki, Alexandra, Toutouzas, Konstantinos G. · 2024 · Current Issues in Molecular Biology
  32. Three Rounds of Stability-Guided Optimization and Systematical Evaluation of Oncolytic Peptide LTX-315
    Xing‐Yan Fu, Hao Yin, Xi‐Tong Chen, Jing-Fang Yao, Yan‐Nan Ma, Min Song, Huan Xu, Qian-Yao Yu, Shanshan Du, Yun‐Kun Qi et al. · 2024 · Journal of Medicinal Chemistry
  33. Magnetically driven capsules with multimodal response and multifunctionality for biomedical applications
    Yuxuan Sun, Zhang Wang, Junnan Gu, Liangyu Xia, Yinghao Cao, Xinhui Zhu, Hao Wen, Shaowei Ouyang, Ruiqi Liu, Jialong Li et al. · 2024 · Nature Communications
  34. Prospects, advances and biological applications of MOF-based platform for the treatment of lung cancer
    Yijun Deng, Manli Guo, Luyi Zhou, Yong Sheng Huang, Shreya Srivastava, Abhinav Kumar, Jian-Qiang Liu · 2024 · Biomaterials Science
  35. Comparing three-dimensional and two-dimensional deep-learning, radiomics, and fusion models for predicting occult lymph node metastasis in laryngeal squamous cell carcinoma based on CT imaging: a multicentre, retrospective, diagnostic study
    Wenlun Wang, Hui Liang, Zhouyi Zhang, Chenyang Xu, Dongmin Wei, Wenming Li, Qian Ye, Lihong Zhang, Jun Liu, Dapeng Lei · 2024 · EClinicalMedicine
  36. Recent deep learning-based brain tumor segmentation models using multi-modality magnetic resonance imaging: a prospective survey
    Zain Ul Abıdın, Rizwan Ali Naqvi, Amir Haider, Hyung Seok Kim, Daesik Jeong, Seung Won Lee · 2024 · Frontiers in Bioengineering and Biotechnology
  37. The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway
    Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, Diamanto M. Lazari, Chrissa Sioka, Spyridon Voulgaris, George Α. Alexiou · 2024 · Cancers
  38. Enhancing EfficientNetv2 with global and efficient channel attention mechanisms for accurate MRI-Based brain tumor classification
    İshak Paçal, Ömer Çelik, Bilal Bayram, António Manuel Trigueiros da Silva Cunha · 2024 · Cluster Computing
  39. CAR-T Cell Therapy: From the Shop to Cancer Therapy
    Ashanti Concepción Uscanga‐Palomeque, Ana Karina Chávez-Escamilla, Cynthia Aracely Alvizo-Báez, Santiago Saavedra-Alonso, Luis Daniel Terrazas-Armendáriz, Reyes Támez-Guerra, Cristina Rodrı́guez-Padilla, Juan Manuel Alcocer-González · 2023 · International Journal of Molecular Sciences
  40. Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
    Stefanie Bärthel, Chiara Falcomatà, Roland Rad, Fabian Joachim Theis, Dieter Saur · 2023 · Nature Cancer
  41. HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept
    Yanjun Hou, Hiroaki Nitta, Zaibo Li · 2023 · Cancers
  42. Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers
    Deborah Wenk, Charlotte Zuo, Thomas Kislinger, Lusia Sepiashvili · 2024 · Clinical Proteomics
  43. Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)
    Otília Menyhárt, János Tibor Fekete, Balázs Győrffy · 2024 · International Journal of Molecular Sciences
  44. Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
    Kuboki, Yasutoshi, Fakih, Marwan, Strickler, John, Yaeger, Rona, Masuishi, Toshiki, Kim, Edward J., Bestvina, Christine M., Kopetz, Scott, Falchook, Gerald S., Langer, Corey et al. · 2024 · Nature Medicine
  45. Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review
    Shijia Zhao, Jie Liu, Zaosheng Lv, Guangde Zhang, Zhi Gang Xu · 2023 · European Journal of Medicinal Chemistry
  46. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients
    Arsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, Sarah J. Parker, Andrew Eugene Hendifar, Pranav Singh, Darya Filippova, Grant Dagliyan, Cristina R. Ferrone, Lei Zheng et al. · 2024 · Nature Cancer
  47. ACOG Clinical Consensus No. 5: Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia
    2023 · Obstetrics and Gynecology
  48. Repressed Blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress
    Ling Ye, Yuanlong Hou, Wanyu Hu, Hongmei Wang, Ruopeng Yang, Qihan Zhang, Qiaoli Feng, Xiao Zheng, Guangyu Yao, Haiping Hao · 2023 · Nature Communications
  49. An All‐Rounder for NIR‐II Phototheranostics: Well‐Tailored 1064 nm‐Excitable Molecule for Photothermal Combating of Orthotopic Breast Cancer
    Dingyuan Yan, Zhijun Zhang, Jianyu Zhang, Xue Li, Qian Wu, Yixiong Gui, Jun Zhu, Miaomiao Kang, Xiaohui Chen, Ben Zhong Tang et al. · 2024 · Angewandte Chemie International Edition
  50. Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging
    Min Jun Ko, Sunhong Min, Hyunsik Hong, Woojung Yoo, Jinmyoung Joo, Yu Shrike Zhang, Heemin Kang, Dong‐Hyun Kim · 2023 · Bioactive Materials
  51. The impact of vitamin D on cancer: A mini review
    Gerbenn Seraphin, Sandra Rieger, Martin Hewison, Enrico Capobianco, Thomas S. Lisse · 2023 · The Journal of Steroid Biochemistry and Molecular Biology
  52. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling
    Qiurong Yang, Maoye Wang, Jing Xu, Dan Bi Yu, Yixin Li, Yanke Chen, Xiaoxin Zhang, Jiahui Zhang, Jianmei Gu, Xu Zhang · 2023 · Molecular Cancer
  53. Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader
    Lawrence B. Snyder, Taavi K. Neklesa, Ryan R. Willard, Debbie Gordon, Jennifer Pizzano, Nicholas Vitale, Kaitlynn Robling, Madeline A. Dorso, Walid N. Moghrabi, Sean F. Landrette et al. · 2024 · Molecular Cancer Therapeutics
  54. Improving outcomes in patients with oesophageal cancer
    Manish A. Shah, Nasser Khaled Altorki, Pretish Patel, Sebron W. Harrison, Adam Joel Bass, Julian A. Abrams · 2023 · Nature Reviews Clinical Oncology
  55. Targeting KRAS in pancreatic cancer
    Sandra Stickler, BARBARA RATH, Gerhard Hamilton · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  56. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
    Qin Qin, Rong Yu, John Eriksson, Hsiang‐i Tsai, Haitao Zhu · 2024 · Cancer Letters
  57. Consensus, debate, and prospective on pancreatic cancer treatments
    Junke Wang, Jie Yang, Amol Kumar Narang, Jing He, Christopher L. Wolfgang, Keyu Li, Lei Zheng · 2024 · Journal of Hematology & Oncology
  58. Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment
    Beatrice Foglia, Cristian Turato, Stefania Cannito · 2023 · International Journal of Molecular Sciences
  59. The clinical relevance of OSM in inflammatory diseases: a comprehensive review
    Cody L. Wolf, Clyde Pruett, Darren Lighter, Cheryl L. Jorcyk · 2023 · Frontiers in Immunology
  60. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma
    Caiming Xu, Eunsung Jun, Yoshinaga Okugawa, Yuji Toiyama, Erkut Hasan Borazanci, John S. Bolton, Akinobu Taketomi, Song Cheol Kim, Dong Shang, Daniel D. Von Hoff et al. · 2023 · Gastroenterology
  61. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 Axes
    Lixian Ding, Shuwei Dang, Mingjun Sun, Dazhi Zhou, Yanyan Sun, Encheng Li, Shuqi Peng, Guodong Li, Guodong Li · 2024 · Free Radical Biology and Medicine
  62. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
    Caili Xu, Min Zhu, Qian Wang, Jiajun Cui, Yuping Huang, Xiting Huang, Jing Huang, Junwei Gai, Guanghui Li, Peng Qiao et al. · 2023 · Journal of Nanobiotechnology
  63. Ensemble Deep Learning-Based Image Classification for Breast Cancer Subtype and Invasiveness Diagnosis from Whole Slide Image Histopathology
    Aadhi Aadhavan Balasubramanian, Salah Alheejawi, Akarsh Singh, Anne Breggia, Bilal Ahmad, Robert Christman, Ryan Stephen T., Saeed Amal · 2024 · Cancers
  64. Deep learning empowered breast cancer diagnosis: Advancements in detection and classification
    Jawad Ahmad, Sheeraz Akram, Arfan Jaffar, Zulfiqar Ali, Sohail Masood Bhatti, Awais Ahmad, Shafiq Ur Rehman · 2024 · PLoS ONE
  65. Oncolytic virus VG161 in refractory hepatocellular carcinoma
    Yinan Shen, Xueli Bai, Qi Zhang, Xingmei Liang, Xinyan Jin, Zeda Zhao, Wei Song, Qian Tan, Ronghua Zhao, William W.-G. Jia et al. · 2025 · Nature
  66. Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality
    Longgang Zhao, Xinyuan Zhang, Mace Coday, David O. Garcia, Xinyi Li, Yasmin Mossavar‐Rahmani, Michelle Joy Naughton, Melissa Lopez‐Pentecost, Nazmus Saquib, Aladdin H. Shadyab et al. · 2023 · JAMA
  67. Attention guided grad-CAM : an improved explainable artificial intelligence model for infrared breast cancer detection
    Kaushik Raghavan, B. Sivaselvan, Veezhinathan Kamakoti · 2023 · Multimedia Tools and Applications
  68. Breast cancer risk prediction using machine learning: a systematic review
    Sadam Hussain, Mansoor Ali, Usman Naseem, Fahimeh Nezhadmoghadam, Munsif Ali Jatoi, Thomas Aaron Gulliver, José G. Tamez‐Peña · 2024 · Frontiers in Oncology
  69. An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer
    Yuan Gao, Sofía Ventura‐Díaz, Xin Wang, Muzhen He, Zeyan Xu, Arlene Weir, Hong-Yu Zhou, Tianyu Zhang, Frederieke H van Duijnhoven, Luyi Han et al. · 2024 · Nature Communications
  70. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
    Edwards, A. Cole, Stalnecker, Clint A., Jean Morales, Alexis, Taylor, Khalilah E., Klomp, Jennifer E., Klomp, Jeffrey A., Waters, Andrew M., Sudhakar, Niranjan, Hallin, Jill, Tang, Tracy T. et al. · 2023 · Cancer Research
  71. Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States
    Li, Shiwen, Oliva, Paulina, Zhang, Lu, Goodrich, Jesse A., McConnell, Rob, Conti, David V., Chatzi, Lida, Aung, Max · 2025 · Journal of Exposure Science & Environmental Epidemiology
  72. Predictive modeling for breast cancer classification in the context of Bangladeshi patients by use of machine learning approach with explainable AI
    Taminul Islam, Md. Alif Sheakh, Mst. Sazia Tahosin, Most. Hasna Hena, Shopnil Akash, Yousef A. Bin Jardan, Gezahign FentahunWondmie, Hiba‐Allah Nafidi, Mohammed Bourhia · 2024 · Scientific Reports
  73. NIR‐II Fluorescent Thermophoretic Nanomotors for Superficial Tumor Photothermal Therapy
    Jiwei Jiang, Jing Hu, Mingtong Li, Mingzhi Luo, Bin Dong, Metin Sitti, Xiaohui Yan · 2025 · Advanced Materials
  74. The function and mechanisms of action of circular RNAs in Urologic Cancer
    Zi-Hao Zhang, Yue Wang, Ya Zhang, Shengfeng Zheng, Tao Feng, Xi Tian, Mierxiati Abudurexiti, Zhen-Da Wang, Wenkai Zhu, Jiaqi Su et al. · 2023 · Molecular Cancer
  75. PARP inhibitors in metastatic prostate cancer
    Amy K. Taylor, David Kosoff, Hamid Emamekhoo, Joshua Michael Lang, Christos E. Kyriakopoulos · 2023 · Frontiers in Oncology
  76. Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15–49 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study
    Zheng Li, Xiaojie Zhang, Chongyuan Sun, Zefeng Li, He Fei, Dongbing Zhao · 2024 · International Journal of Surgery
  77. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments
    Emina Karahmet Sher, Mirna Alebić, Marijana Marković Boras, Emina Boškailo, Esma Karahmet Farhat, Alma Karahmet, Bojan Pavlović, Farooq Sher, Lana Lekić · 2024 · International Journal of Pharmaceutics
  78. Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment
    Dimitrios C. Ziogas, Charalampos Theocharopoulos, Peter Lialios, Dimitra Foteinou, Ioannis‐Alexios Koumprentziotis, Georgios Xynos, Helen J Gogas · 2023 · Cancers
  79. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
    Peter J. Mazzone, Peter Brian Bach, Jacob Carey, Caitlin A. Schonewolf, Katalin Bognar, Manmeet Singh Ahluwalia, Marcia Roxana Cruz-Correa, David S. Gierada, Sonali Kotagiri, Kathryn Lloyd et al. · 2024 · Cancer Discovery
  80. Quasi Fe MIL-53 nanozyme inducing ferroptosis and immunogenic cell death for cancer immunotherapy
    Zihui Yan, Yang Bai, Songtao Zhang, Lingyi Kong, Yu Wang, Huilin Sun, Yi Li, Lin Qiu, Ruijie Zhang, Pengju Jiang et al. · 2025 · Nature Communications
  81. Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study
    Ignace B. Vergote, Els Van Nieuwenhuysen, Roisin Eilish O'Cearbhaill, Anneke M. Westermann, Domenica Lorusso, Sharad A. Ghamande, Dearbhaile Catherine Collins, Susana N. Banerjee, Cara Amanda Mathews, Christine Gennigens et al. · 2023 · Journal of Clinical Oncology
  82. Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment
    Shu Zhang, Xiaojuan Zhang, Huan Gao, Xiaoqin Zhang, Lidan Sun, Yueyan Huang, Jie Zhang, Baoyue Ding · 2024 · Pharmaceutics
  83. Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0
    Gebrael, Georges, Sahu, Kamal Kant, Chigarira, Beverly, Tripathi, Nishita, Mathew Thomas, Vinay, Sayegh, Nicolas, Maughan, Benjamin L., Agarwal, Neeraj, Swami, Umang, Li, Haoran · 2023 · Cancers
  84. Biomarkers and targeted therapy for cancer stem cells
    Yusheng Liu, Hua Wang · 2023 · Trends in Pharmacological Sciences
  85. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway
    Kai Lin, Endi Zhou, Ting Shi, Siqing Zhang, Jinfan Zhang, Ziruo Zheng, Yuetian Pan, Wentao Gao, Yabin Yu · 2023 · Journal of Experimental & Clinical Cancer Research
  86. Oral Nanomedicine: Challenges and Opportunities
    Bo Deng, Shaomin Liu, Ying Wang, Barkat Ali, Na Kong, Tian Xie, Seyoung Koo, Jiang Ouyang, Wei Tao · 2023 · Advanced Materials
  87. Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer
    Cassandra D. L. Fritz, Ebunoluwa E. Otegbeye, Xiaoyu Zong, Joshua Demb, Katelin B. Nickel, Margaret A A Olsen, Matthew G. Mutch, Nicholas Davidson, Samir Gupta, Yin Cao · 2023 · JNCI Journal of the National Cancer Institute
  88. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
    Shailendra Kumar Gautam, Surinder K. Batra, Maneesh Jain · 2023 · Molecular Cancer
  89. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation
    Yongbo Yu, Ye Liang, Fei Xie, Zhao Zhang, Pengfei Zhang, Xinzhao Zhao, Zhilei Zhang, Zhijuan Liang, Dan Li, Liping Wang et al. · 2024 · Cancer Letters
  90. The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN
    Tao Jiang, Junwen Qi, Zhenyu Xue, Bowen Liu, Jianquan Liu, Qihang Hu, Yuqiu Li, Jing Ren, Song Hu, Yixin Xu et al. · 2024 · Molecular Cancer
  91. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
    Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, Monia Cecati, Giulio Milanese, Davide Sartini, Eleonora Salvolini, Andrea Benedetto Galosi, Monica Emanuelli · 2023 · Cancers
  92. Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
    Xue Bai, Zhiguang Duan, Jianjun Deng, Zhuo Zhang, Rongzhan Fu, Chenhui Zhu, Daidi Fan · 2024 · Journal of Advanced Research
  93. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring
    Xiang-Yuan Tao, Qianqian Li, Yong Zeng · 2024 · Molecular Cancer
  94. Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study
    Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvåle, Diego Serraino, Valentina Lorenzoni, Anssi P. Auvinen, Luigino Dal Maso · 2024 · BMJ
  95. Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis
    Chiara Molinelli, Flavia Jacobs, Elisa Agostinetto, Guilherme Nader Marta, Marcello Ceppi, Marco Bruzzone, Eva Blondeaux, Francesco Schettini, Aleix Prat, Giuseppe Viale et al. · 2023 · ESMO Open
  96. Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies
    Ye Yang, Su Fang Wu, Wei Bao · 2023 · International Journal of Gynecology & Obstetrics
  97. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
    Dechao Feng, Weizhen Zhu, Jie Wang, Dengxiong Li, Xu Shi, Qiao Xiong, Jia You, Ping Han, Shi Qiu, Qiang Wei et al. · 2024 · Military Medical Research
  98. The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
    Rodrigo Romero, Tinyi Chu, Tania J González-Robles, Perianne Smith, Yubin Xie, Harmanpreet Kaur, Sara Yoder, Huiyong Zhao, Chenyi Mao, Wenfei Kang et al. · 2024 · Nature Cancer
  99. The application of Aptamer in biomarker discovery
    Yongshu Li, Winnie W. L. Tam, Yuanyuan Yu, Zhenjian Zhuo, Zhichao Xue, Chiman Tsang, Xiaoting Qiao, Weijing Wang, Weijing Wang, Yongyi Li et al. · 2023 · Biomarker Research
  100. A Comprehensive Review of Inorganic Sonosensitizers for Sonodynamic Therapy
    Peng Chen, Ping Zhang, Navid Hussain Shah, Yanyan Cui, Yaling Wang · 2023 · International Journal of Molecular Sciences